Update on the Risk of Primary and Recurrent HCC?With the Use of DAA Therapy for HCV Infection

Jordan Feld MD MPH

首页> 外文期刊>Gastroenterology & Hepatology >Update on the Risk of Primary and Recurrent HCC?With the Use of DAA Therapy for HCV Infection

【24h】

Update on the Risk of Primary and Recurrent HCC?With the Use of DAA Therapy for HCV Infection

机译：使用DAA疗法治疗HCV感染的原发性和复发性HCC风险更新

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

G&H? What is the current understanding of the relationship between hepatocellular carcinoma and hepatitis C virus infection?

机译：G＆H？目前对肝细胞癌和丙型肝炎病毒感染之间的关系有何了解？

著录项

来源
《Gastroenterology & Hepatology》 |2019年第6期|共页
作者
Jordan Feld MD MPH;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类消化生理学;
关键词

相似文献

外文文献
中文文献
专利

1. Rates of sustained virological response 12?weeks after the scheduled end of direct‐acting antiviral ( DAA DAA )‐based hepatitis C virus ( HCV HCV ) therapy from the National German HCV HCV registry: does HIV HIV coinfection impair the response to DAA DAA combination therapy? [J] . Bischoff J, Mauss S, Cordes C, HIV medicine . 2018,第4期

机译：持续的病毒学响应率12？周末直接作用抗病毒（DAA DAA）基于国家德国HCV HCV登记处的丙型肝炎病毒（HCV HCV）治疗后：HIV HIV辛融合损害对Daa Daa组合的反应损害治疗？
2. After HCC: DAA Therapy for HCV Infection Patients significantly reduces Mortality Risk [J] . Gappa Birgit Zeitschrift fur Gastroenterologie . 2020,第1期

机译：HCC后：治疗HCV感染患者的治疗明显降低死亡率风险
3. The incidence of Denovo HCC or aggressive recurrence of HCC in patients with HCV infection receiving DAA therapy. [J] . Yousif Sarra, Al-Hamoudi Waleed K., Abaalkhail Faisal A., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：HCV感染患者HCV感染患者的丹豚HCC或HCC侵袭性复发的发病率。
4. A study on the fluctuation of HCV antigens during hemodialysis therapy of dialysis patients with the HCV infection using Langmuir's adsorption isotherm [C] . Kotera Hirohisa, Yashiro Masatomo, Ohashi Atsushi, 2012 ICME International Conference on Complex Medical Engineering . 2012

机译：用朗缪尔吸附等温线研究血液透析患者HCV感染过程中HCV抗原的波动
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Update on the Risk of Primary and Recurrent HCC With the Use of DAA Therapy for HCV Infection [O] . Jordan Feld 2019

机译：使用DAA治疗HCV感染的原发性和复发性HCC风险更新
7. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? [O] . J Bischoff, S Mauss, C Cordes, 2018

机译：直接作用抗病毒（DAA）的丙型肝炎病毒（HCV）治疗的预定结束后12周持续持续的病毒学响应率：HIV繁殖会损害对DAA组合治疗的反应吗？
8. Guidance for Industry: Lookback for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV, August 2007 and update December 2010 [R] . 2010

机译：行业指南：丙型肝炎病毒（HCV）的回顾：产品检疫，收货人通知，进一步检测，产品处置和输血受体通知基于供体检测结果表明HCV感染，2007年8月和2010年12月更新

Update on the Risk of Primary and Recurrent HCC?With the Use of DAA Therapy for HCV Infection

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅